MedTrace Logo

Changes in Iron Markers Following Iron Loading in Hemodialysis Patients

NCT00308490 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2007-03-13

No results posted yet for this study

Summary

The purpose of this study is to describe alterations of serum ferritin, transferrin saturation, soluble transferrin receptor, % hypochromic erythrocytes, % reticulocytes, reticulocyte hemoglobin content after iron loading in hemodialysis patients.

Conditions

  • Anemia in Chronic Renal Disease

Interventions

DRUG

iron sucrose

Sponsors & Collaborators

  • Papageorgiou General Hospital

    lead OTHER

Principal Investigators

  • Efstathios Mitsopoulos, MD · Papageorgiou General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2007-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308490 on ClinicalTrials.gov